<DOC>
	<DOCNO>NCT02304523</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy CDFR0612 CDFR0613 compare PEG+picosulfate ( Coolprep Powder ) preparation . The effectiveness bowel cleanse assessed Harefield Cleansing Scale ( HCS ) blind assessor .</brief_summary>
	<brief_title>Safety Efficacy CDFR0612 CDFR0613 Bowel Cleansing Before Colonoscopy</brief_title>
	<detailed_description>This study prospective , randomize , single-blinded , parallel , 3-treatment , multi-center clinical trial . A total 297 subject schedule colonoscopy participate study assign 3 group - CDFR0612 , CDFR0613 , comparator ( Coolprep Powder ) . A subject admit hospital one day colonoscopy administrate study drug . In early morning day colonoscopy , he/she administrate study drug . Any subject carefully monitor safety hospitalisation ( 1 night ) additional 4 week follow-up period study first human trial CDFR0612 CDFR0613 .</detailed_description>
	<mesh_term>Colonic Diseases</mesh_term>
	<criteria>Patients inform give consent voluntary Patients schedule colonoscopy BMI 19≤ &lt; 30 Patients participate interventional study participate within 30 day screen Pregnant breastfeed woman want stop breastfeeding Women childbearing potential agree appropriate contraception study Patients experience hypersensitivity study drug ingredient Uncontrolled hypertension Arrhythmia clinically significant finding EKG Congestive heart failure ; NYHA functional class III IV ; unstable coronary artery disease ; myocardiac infarction history within 6 month Uncontrolled diabetes Active infection except acute upper respiratory infection local skin infection ; Fever ( 38 °C high ) within 1 week study administration HIV infection and/or chronic hepatitis B C Patients difficulty participate severe nausea vomit Suspected confirm inflammatory bowel disease , toxic colon toxic megacolon , gastrointestinal obstruction perforation ; visible bleed colon History colon surgery abdominal surgery within 6 month ; need emergency surgery Colonoscopy follow use : treatment bleed lesion vascular malformation , ulceration , neoplasia , polypectomy site ( e.g. , electrocoagulation , heater probe , laser injection therapy ) ; foreign body removal ; decompression acute nontoxic megacolon sigmoid volvulus ; balloon dilation stenotic lesion ( e.g. , anastomotic stricture ) ; palliative treatment stenosing bleed neoplasm ( e.g. , laser , electrocoagulation , stenting ) Fluid electrolyte ( Na , K , Ca , Mg , chloride , bicarbonate ) disturbance Severe dehydration risk ( e.g. , rhabdomyolysis , ascites ) Dialysis renal disorder ( creatinine clearance &lt; 15ml/min ) Suspected pulmonary aspiration gag reflex disorder History hypersensitivity drug others Alcohol drug abuse within 6 month Clinically significant underlying disease medical history investigator 's discretion Inability written/verbal communication</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Colonoscopy preparation</keyword>
	<keyword>Bowel cleansing</keyword>
	<keyword>Colon cleansing</keyword>
	<keyword>Colonoscopy</keyword>
	<keyword>CDFR0612</keyword>
	<keyword>CDFR0613</keyword>
</DOC>